因医院工作需要，现面向社会招聘以下工作人员（见附件）。

一、报名

①请有意应聘者，通过“医院官网→招聘信息→医院招聘简历投递系统”进行网上投递。

投递地址：https://hr.ahswmu.cn:32120/zhaopin/index.html

②请有意应聘者，加入2021年西南医大附院招聘1群（764855200）、2群（615427366），加入其中一个QQ群即可，请勿重复加群。

简历投递截止时间为2021年12月10日，欢迎广大求职者前来我院应聘。

注意：1、护理人员在投递简历时，求职意向科室请选择“护理人员”。

2、优秀博士不受招聘名额限制。

二、注意事项

1、因疫情防控的需要，请所有人员在现场确认及后续考核时佩戴口罩、接受体温检测，并出示健康码。相关流行病学调查及核酸检测要求等将在QQ群另行通知。

2、应聘人员提供的个人信息、资料应真实可靠。凡弄虚作假，或在考核过程中作弊的应聘人员，一经查实，将取消其应聘资格，并以后不得参与我院任何招聘。我们承诺对应聘者提供的所有资料保密，应聘材料概不退还。

3、应聘人员应保持手机畅通状态，关注招聘QQ群，并及时查看QQ群发送的招聘通知消息，人力资源部不再通知个人。如因个人原因未及时查看通知而未参加报名、资格审查、考试、体检的，属自动放弃。

4、网上报名时间截止后，将不可更改报名信息。应聘人员要使用在有效期内的第二代居民身份证进行报名，报名与考场使用的身份证必须一致。

5、资格审核贯穿招聘工作的全过程，一经发现弄虚作假或与资格要求不符者，将随时取消应聘资格。

6、对有违纪违规记录、以及其他不符合应聘条件的人员，经核实取消其应聘资格。

附件：2021年西南医科大学附属医院人才需求计划（附后）

人力资源部联系电话：0830-3165067，0830-3165543，来电时请说明是在高校人才网看到的信息。

西南医科大学附属医院

2020年12月1日

医院简介

西南医科大学附属医院创建于1950年8月，位于四川省泸州市，是四川省卫生健康委员会直属三级甲等综合医院。服务于川渝滇黔四省市结合区域近4000万群众。医院现有忠山、康健中心两个院区，忠山院区占地面积238亩，建筑总面积16.9万平方米，康健中心院区占地面积538亩，一期完成建筑面积18.3万平方米，两个院区获批编制床位4200张，设有临床、医技科室65个，2019年全年门急诊人次220余万，出院人次近14万，手术人次近9万，是集医疗、教学、科研、预防和康复为一体的综合性临床教学医院。

医院有职工近4600人，其中专业技术人员4200余人，博士、硕士1400余人，高级职称600余人，省级学术和技术带头人8人、后备人才67人，享受国务院政府特殊津贴专家22人，天府名医4人，教育部“新世纪优秀人才支持计划”1人，四川省突出贡献优秀专家15人，四川省卫生健康首席专家3个，四川省卫生健康领军人才4人，担任省级医学会主任委员、候任主任委员及副主任委员50余人，引进外籍专家10人。

医院拥有PET-CT、Micro PET-CT、3.0T磁共振、256层螺旋极速CT、直线加速器、DSA、SPECT、全飞秒激光近视治疗仪、3D腹腔镜等价值约15亿元的大中型现代化仪器设备。

医院不断推进医疗技术国际化，推动亚专业蓬勃发展。1967年成功开展断肢再植术；1979年成功开展心内直视术；1980年成功开展同种异体肾移植；2004年成功开展四川省首例连体婴儿分离术；2005年成功开展四川省首例同种异体心脏移植手术。2007年成功开展第二例心脏移植术，该患者是四川省同种异体原位心脏移植手术后存活时间最长的纪录保持者。近年来相继开展了各种微创外科手术、脑卒中筛查与防治、人类辅助生殖技术、人工耳蜗置入、异基因造血干细胞移植等新技术。医院是国家“高级卒中中心”和“中国胸痛中心”，国家标准化代谢性疾病管理中心，国家日间手术试点医院，先天性结构畸形救助定点医疗机构，国家首批罕见病诊疗协作网成员医院，川渝滇黔结合区域危急重症及疑难疾病诊疗中心，全国人工肝及血液净化技术示范中心，甲状（旁）腺疾病规范化诊疗示范基地，四星数字化医院。

医院现有临床医学、麻醉学、医学影像学、医学影像技术、医学检验技术、康复治疗学、儿科学、眼视光学、健康服务与管理等9个本科专业；有院内外博士、硕士研究生导师近460人；临床医学为硕士学位授权一级学科；临床医学专业、麻醉学专业为国家级特色专业，临床医学专业为国家级一流本科专业建设点、四川省应用型本科示范专业，康复治疗学、麻醉学专业为四川省一流本科专业建设点。拥有1个国家级大学生校外实践教学基地、1个国家级卓越医生教育培养计划试点项目、8门省级精品开放（资源共享）课程、3门省级双语教学课程、3个省级教学团队、4个省级重点（建设）学科、首批国家临床教学培训示范中心、3门省级应用性示范课程、1门省级”课程思政”课程；全国首批“中国医师协会腹腔镜外科医师培训基地”、全国首批住院医师规培基地（26个专业基地），首个专科医师培训基地“儿科围产期医学专科培训基地”。截至2018年，医院学子在全国高等医学院校临床技能大赛中获得西南西北赛区特等奖一次、一等奖六次；全国二等奖三次、三等奖四次。

医院在2018年复旦版《中国医院排行榜》西南区医院综合实力排行榜上排名第16名；2019年度中国医院科技量值（STEM）中共有麻醉学、麻醉学、呼吸病学、结核病学、消化病学、血液病学、肾脏病学、内分泌病学与代谢病学、风湿病学与自体免疫病学、变态反应学、传染病学、普通外科学、神经外科学、骨外科学、烧伤外科学、整形外科学、耳鼻咽喉科学、皮肤病学、神经病学、精神病学、急诊医学、护理学共21个学科上榜。2020年7月，临床医学学科位列ESI全球学科排名前1%，学科排名第2586位，百分比排位56.64%；在艾力彼医院管理研究中心发布的《医院蓝皮书》中国医院竞争力报告（2019-2020）中，医院在“2019届中国医院竞争力•地市级医院100强”排行榜单上排名第23位。

医院现有1个国家临床重点建设专科，4个四川省重点（培育）学科、四川省医学重点学科（实验室）26个、四川省中医重点专科1个。医院拥有国家药物临床试验机构、核医学与分子影像四川省重点实验室、四川省临床医学研究中心（神经外科、出生缺陷、肾脏疾病）、四川省骨科置入器械研发及应用技术工程实验、四川省院士工作站、心血管代谢病泸州市重点实验室共8个国家、省、市级科研平台，医院以各省级平台为基础，整合相关学科实验室以及医学实验中心、生物样本库两大公共平台，于2018年10月成立西南医科大学附属医院临床医学研究中心。同时医院与澳门大学、西南医科大学联合成立精准医学研究中心，与德国癌症研究中心、海德堡大学共同建设细胞与分子病理学联合实验室，脑血管病项目入选国家发改委疑难病症诊治能力提升工程。目前在研科研项目1500余项；2019年发表SCI文章246篇；近五年，以第一完成单位或参研单位获得省部级及以上科技成果奖27项，其中参研获得国家科技进步二等奖1项，教育部高等学校科学研究优秀成果奖（科学技术）二等奖1项。截止2019年，医院以第一完成单位获得四川省科技进步奖一等奖5项。

医院不断加强国际交流与合作，与英国赫尔大学、日本昭和医科大学以及金泽医科大学、德国海德堡大学、波恩大学以及埃尔朗根大学等建立了稳定的学术往来和友好合作关系。

医院始终以“提高人民群众的卫生与健康水平”为己任，在公共事件、突发应急抢险中，如：抗击新型冠状病毒感染的肺炎疫情、抗震救灾、煤矿瓦斯爆炸、抗击非典等处置中，展现出极强的应急救援及抢救能力和高救治成功率，持续满足社会对医疗的更高需求。

展望未来，医院全体职工将不忘初心、牢记使命，为实现“一流学科、一流医院”的发展目标而努力奋斗!

 Affiliated Hospital of Southwest Medical University was founded in August 1950, and situated in Luzhou of Sichuan Province, it is a Class A Grade Ⅲ Hospital which is directly subordinated to the Health Commission of Sichuan Province. The hospital serves for the population of nearly 40 million in the bordering areas of Sichuan province, Yunnan province, Guizhou province and Chongqing Municipality. The hospital consists of 2 geographic parts which are Zhongshan Hospital and Health Center respectively. Zhongshan Hospital covers the area of 169,000㎡, Health Center has the area of 538 Mu, among which the Phase 1 construction owns the area of 183,000㎡. There are 4200 ward beds, 75 clinical and technical departments in the 2 parts combined. In 2019, there are over 2.2 million outpatients and emergency patients, close to 140,000 patients were admitted, and nearly 90,000 patients underwent procedures. It is a university hospital that undertakes the tasks of medical treatment, medical education, scientific research, diseases prevention and rehabilitation service.
There are nearly 4600 employees, among whom more than 4200 are specialists, over 1400 holds a master or doctor degree, over 600 holds an advanced professional title, 8 are provincial academic or technical leaders, 67 are in the talent reservoir, 22 enjoys the special subsidy granted by the State Council, 4 are Tianfu Famous Doctors, 1 is selected into “New Century Outstanding Talent Project” by National Education Ministry, 15 are remarkable experts of Sichuan Province, over 50 are either the chairman, the deputy-chairman or the next chairman of various medical societies at provincial level, and 10 are foreign experts.
The hospital owns approximately 1.5 billion worthy of large-size medical equipments such as PET-CT, Micro PET-CT, 3.0 MRI Scanner, 256 Multi-detector Spiral CT, Linear Accelerator, DSA, ETC, Femto-second laser therapeutic instrument for myopia, 3D Laparoscope, etc.  
The hospital has continuously promoted the globalization of medical technology, and developed medical subspecialities. Replantation for mutilated limbs was successfully performed in 1967; Direct vision intracardiac operation was successfully performed in 1979; Allogeneic kidney transplantation was successfully carried out in 1980; the first case of separation of Siamese twins in Sichuan Province was successfully operated in 2004; the first case of allogeneic heart transplantation in Sichuan province was successfully performed in 2005; the 2nd case of heart transplantation was carried out in 2007, and this patient helds the record of the longest post-op survival time for allogeneic heart transplantation in Sichuan Province. In recently years, a series of new projects were launched in succession, including a variety of minimally invasive surgeries, screenin & prevention and treatment of stroke, assisted reproductive technology, atificial cochlea implantation, allogene hemopoietic stem cell transplantation, etc. The hospital is also a national Advanced Stroke Center, a China Chest Pain Center, a National Netabolic Management Center, a National Experimental hospital for day surgery, a designated assistance hospital for congenitally structural malformation, the first batch of network hospitals for rare diseases, a medical center for critical and complicated illness in the bordering areas of Sichuan province, Yunnan province, Guizhou province and Chongqing Municipality, a national exemplary center for artificial liver and blood purification, an exemplary standardized training base for thyroid and parathyroid gland diseases, a 4 star digitial hospital.
Currently the hospital offers 9 bachelor degrees, ranging from clinical medicine, anesthesiology, medical imageology, medical imaging technology, laboratory medicine to rehabilitation, pediatrics, ophthalmology, health management. There are nearly 460 master’s supervisors or doctor’s supervisors. Clinical medicine is a first degree major of master’s degree. Clinical medicine and anesthesiology are national featured majors. Clinical medicine is a natioanl top-grade bachelor degree constructing major, an exemplary major for applied bachelor degree in Sichuan Province. Rehabilitation and anesthesiology are both provincial bachelor degree constructing major. There is 1 national undergraduate off-campus practice teaching base and 1 national outstanding doctors cultivation project pilot program, 8 provincial finest open source courses, 3 provincial bilingual courses, 3 provincial teaching teams, 4 provincial key or key constructing disciplines, the 1st batch of national clinical teaching exemplary center, 3 provincial applied demonstration courses, the first national batch for “Laparoscope training base for Chinese doctors association”, the first national batch for resident training base (26 specialties base), the first speciality doctor training base “ Pediatric perinatal medicine speciality training base”. Until 2018, the students of the hospital has won 1 special prize, 6 1st prize in the southwest and northwest region of the national higher medical school clinic skills competition. And 3 2nd prize and 4 3rd prize in the national region.
In the Fudan “2018 Chinese Hospital ranking”, the hospital has ranked 16^th in the southwest division. In the 2019 Chinese Hospital Science and Technology Evaluation Metrics (STEM), 21 departments were listed including Anesthesiology, respiratory diseases, phthisiology, gastroenterolgoy, hematology, Nephrology, endocrinology, Rheumatology, Allergology, Infectious Diseases, General Surgery, Neurosurgery,, Orthopedics, Burn Surgery, Plastic Surgery, Otolaryngology, Dermatology, Neurology, Psychiatry, Emergency Medicine, , Nursing, etc. In July 2020, clinical medicine ranks among the top 1% of global ESI major rankings, ranked at 2586^th and 56.64% in percentage.  In the ranking of Alibi Hospital Management of China(2019-2020), the hospital has ranked 23^rd in the category of competitveness of hospital at municipal level.
The hospital boasts 1 national clinical key constructing subject, 4 provincial key subjetcs, 26 provincial medical key subjects(labs) and 1 provincial TCM key subject. In addition, there are 9 research platforms at national, provincial or municipal level including national clinical drug trial institution, Sichuan Key Lab—nuclear medicine and molecular imaging, Provincial research center for clinical medicine ( Neurosurgery, Birth defect, Renal diseases), Sichuan Engineering Lab for embedded orthopedics apparatus R&D, Sichuan Academician work station and municipal key lab for cardiovascular metabolic diseases. On the basis of various provincial platforms, the hospital has integrated relevant labs and the 2 major public platforms—Medical Lab Center and Biological Sample Bank to establish Clinical Medicine Research Center of Affiliated Hospital of Southwest Medical University in Oct 2018. Meanwhile, it established precision medicine research center with Macau University and Southwest Medical University, co-found “Cell and molecular pathology collaborative Lab” with German Cancer Research Center of Heidelberg University, participated in the national cerebrovascular complicated diseases diagnostics and therapy program. Currently there are over 1500 on-going research projects; 246 SCI papers were published in 2019; For the last 5 years, the hospital has won 27 technology improvement prize in provincial or national level as the first institute or participant institute, among which is 1 national technology improvement 2^nd prize as paticipant institute, 1 Scientific Research Achievement 2^nd prize of Tertiary Institution By the Ministry of Education. Up to 2019, the hospital has won 5 provincial technology improvement 1^st prize as the first institute.
The hospital is always strengthening international cooperation and exchange. It forms steady and friendly collaboration with Hull University in UK, Showa University and Kanazawa Medical University in Japan, Heidelberg University, University of Bonn and Erlangen University in Germany. 
The hospital consistently regards “improve the masses health” as the ultimate duty. It shows extraodinary emergency rescue capability and high slavage rate in public events such as fighting against 2019 novel coronavirus, first-aid in earthquake and mine gas explosion, and overseas medical aid. The hospital has never failed the high expectation of the society.
Look forward to the future, every staff of the hospital is going to remain true to their original aspiration and keep the mission firmly in mind. They will constantly strive for the goal of “ top-grade departments, top-grade hospital”.